Inchoate CD8\u3csup\u3e+\u3c/sup\u3e T cell responses in neonatal mice permit influenza-induced persistent pulmonary dysfunction by You, Dahui et al.
Louisiana State University 
LSU Digital Commons 
Faculty Publications Department of Biological Sciences 
9-1-2008 
Inchoate CD8+ T cell responses in neonatal mice permit influenza-
induced persistent pulmonary dysfunction 
Dahui You 
LSU Health Sciences Center - New Orleans 
Michael Ripple 
Louisiana State University 
Shrilatha Balakrishna 
LSU Health Sciences Center - New Orleans 
Dana Troxclair 
LSU Health Sciences Center - New Orleans 
Dane Sandquist 
LSU Health Sciences Center - New Orleans 
See next page for additional authors 
Follow this and additional works at: https://digitalcommons.lsu.edu/biosci_pubs 
Recommended Citation 
You, D., Ripple, M., Balakrishna, S., Troxclair, D., Sandquist, D., Ding, L., Ahlert, T., & Cormier, S. (2008). 
Inchoate CD8+ T cell responses in neonatal mice permit influenza-induced persistent pulmonary 
dysfunction. Journal of Immunology, 181 (5), 3486-3494. https://doi.org/10.4049/jimmunol.181.5.3486 
This Article is brought to you for free and open access by the Department of Biological Sciences at LSU Digital 
Commons. It has been accepted for inclusion in Faculty Publications by an authorized administrator of LSU Digital 
Commons. For more information, please contact ir@lsu.edu. 
Authors 
Dahui You, Michael Ripple, Shrilatha Balakrishna, Dana Troxclair, Dane Sandquist, Liren Ding, Terry A. 
Ahlert, and Stephania A. Cormier 
This article is available at LSU Digital Commons: https://digitalcommons.lsu.edu/biosci_pubs/898 
of October 4, 2021.
This information is current as
Pulmonary Dysfunction
Mice Permit Influenza-Induced Persistent 
 T Cell Responses in Neonatal+Inchoate CD8
Stephania A. Cormier
Troxclair, Dane Sandquist, Liren Ding, Terry A. Ahlert and 
Dahui You, Michael Ripple, Shrilatha Balakrishna, Dana
http://www.jimmunol.org/content/181/5/3486
doi: 10.4049/jimmunol.181.5.3486
2008; 181:3486-3494; ;J Immunol 
References
http://www.jimmunol.org/content/181/5/3486.full#ref-list-1
, 15 of which you can access for free at: cites 40 articlesThis article 
        average*
   
 4 weeks from acceptance to publicationFast Publication! •  
   
 Every submission reviewed by practicing scientistsNo Triage! •  
   
 from submission to initial decisionRapid Reviews! 30 days* •  
   
Submit online. ?The JIWhy 
Subscription
http://jimmunol.org/subscription
 is online at: The Journal of ImmunologyInformation about subscribing to 
Permissions
http://www.aai.org/About/Publications/JI/copyright.html
Submit copyright permission requests at: 
Email Alerts
http://jimmunol.org/alerts
Receive free email-alerts when new articles cite this article. Sign up at: 
Print ISSN: 0022-1767 Online ISSN: 1550-6606. 
Immunologists All rights reserved.
Copyright © 2008 by The American Association of
1451 Rockville Pike, Suite 650, Rockville, MD 20852
The American Association of Immunologists, Inc.,
 is published twice each month byThe Journal of Immunology
























Inchoate CD8 T Cell Responses in Neonatal Mice Permit
Influenza-Induced Persistent Pulmonary Dysfunction1
Dahui You,*† Michael Ripple,† Shrilatha Balakrishna,* Dana Troxclair,‡ Dane Sandquist,‡
Liren Ding,2* Terry A. Ahlert,* and Stephania A. Cormier3*
Influenza infection remains a significant cause of pulmonary morbidity and mortality worldwide, with the highest hospitalization
and mortality rates occurring in infants and elder adults. The mechanisms inducing this considerable morbidity and mortality are
largely unknown. To address this question, we established a neonatal mouse model of influenza infection to test the hypothesis that
the immaturity of the neonatal immune system is responsible for the severe pulmonary disease observed in infants. Seven-day-old
mice were infected with influenza A virus (H1N1) and allowed to mature. As adults, these mice showed enhanced airway hyper-
reactivity, chronic pulmonary inflammation, and diffuse emphysematous-type lesions in the lungs. The adaptive immune responses
of the neonates were much weaker than those of adults. This insufficiency appeared to be in both magnitude and functionality and
was most apparent in the CD8 T cell population. To determine the role of neonatal CD8 T cells in disease outcome, adult, naive
CD8 T cells were adoptively transferred into neonates before infection. Neonatal mice receiving the adult CD8 T cells had
significantly lower pulmonary viral titers and greatly improved pulmonary function as adults (airway resistance similar to
SHAM). Additional adoptive transfer studies using adult CD8 T cells from IFN--deficient mice demonstrated the importance
of IFN- from CD8 T cells in controlling the infection and in determining disease outcome. Our data indicate that neonates are
more vulnerable to severe infections due to immaturity of their immune system and emphasize the importance of vaccination in
infants. The Journal of Immunology, 2008, 181: 3486–3494.
E ach year influenza viruses cause significant morbidity andmortality (1). Influenza virus A, in particular, has beenshown to elicit respiratory illnesses such as pneumonia
and bronchiolitis and to exacerbate underlying respiratory diseases
such as chronic obstructive pulmonary disease (COPD)4 and
asthma (2). In fact, from October 2006 to May 2007, 23,753 spec-
imens tested positive for influenza viruses in collaborating labo-
ratories of the World Health Organization and the National Respi-
ratory and Enteric Virus Surveillance System in the United States;
of the influenza-positive specimens, 79% were influenza A viruses
and 62% of these were of the H1 subtype (http://www.cdc.gov/
flu/weekly/weeklyarchives2006–2007/06–07summary.htm). In-
terestingly, the highest incidence of illness occurs in preschool and
school age children, with 20–30% of children in this age group
being diagnosed with influenza infections each year (3–6). In-
fected infants younger than 6 mo of age have higher hospitaliza-
tion and mortality rates than do older children (7, 8). Complica-
tions of influenza infections in infants typically include lower
respiratory tract involvement and, although these infections occur
less frequently than respiratory syncytial virus (RSV) infections in
infants, they are also a significant cause of wheeze (9). Epidemi-
ological data demonstrate that infection of infants with influenza
can lead to chronic pulmonary distress and furthermore that the
effects of influenza in this population are underestimated and may
be responsible for previously unexplained chronic pulmonary dys-
function (10).
To understand how influenza induces pulmonary illness, various
animal models have been used, including ferrets, rats, chickens,
and mice (11). While neutralizing Abs to influenza are important
for protection from viral infection, CD8 T cells have been shown
to play a pivotal role in viral clearance and recovery from the
illness in adult mice. CD8 T cell-deficient mice exhibit delayed
viral clearance and significantly higher mortality when challenged
with a sublethal dose of influenza (12). Additionally, in B cell-
deficient mice, adoptive transfer of CD8 T cells promotes more
rapid clearance of the virus and recovery from illness (13, 14).
Despite the global burden of influenza infection in infants and
children, very few studies have examined the pathogenesis of in-
fection in an infant model. The infant and neonatal immune sys-
tems are immature and this immaturity contributes to the patho-
genesis of various lower respiratory tract infections, including
influenza, RSV, and others. Lower respiratory tract viral infections
in infants are often associated with acute and persistent pulmonary
dysfunction, which is characterized by increased airway resistance
and hyperresponsiveness (15–17). Previously, we and other groups
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have described a neonatal mouse model (i.e., 7 days of age at
initial infection) of RSV infection (18–20). In this model, the age
of primary infection determined the immunological nature (Th1 or
Th2) of the secondary infection. Th2 immune responses dominated
upon secondary infection, if the primary infection occurred at 1 wk
or less of age; while Th1 responses dominated if the mice were
primarily infected as adults (8 wk old) (18). Interestingly, a single
infection with RSV in neonatal mice induced long-term pulmonary
dysfunction (20), which was exacerbated upon secondary infection
with RSV (19). The RSV neonatal model demonstrated that the
age at which the initial infection occurred is critical in determining
the subsequent host immune response to the pathogen; further-
more, it suggested that if the infection occurs too early, the im-
mature immune response contributes to pathogenesis instead of
protection.
A recent study in human infants suggests that a failure to de-
velop a cytotoxic T lymphocyte response is responsible for the
high rate of infant morbidity and mortality caused by respiratory
viruses (21). The article demonstrated that in both fatal infant in-
fluenza and RSV infection, CD4 and CD8 T cells were present
in the lung at very low frequency. Additionally, granzyme-produc-
ing cells (either cytotoxic CD8 T cells or NK cells) were not
observed in the lungs of infants with fatal influenza virus infection
and correlated with massive viral replication and apoptosis of in-
flammatory cells.
To understand the relationships among the type of respiratory
virus, the pulmonary immune response and the long-term pulmo-
nary pathophysiology after infection in infancy, we established a
neonatal (7 days of age) mouse model of influenza A virus infec-
tion. In this model, neonatal infection induced long-term pulmo-
nary inflammation and airway injury and dysfunction accompanied
with a weak CD8 T cell response (lower number and lower
IFN- production in CD8 T cells). To examine if the weak CD8
T cell response played a role in the pathogenesis of influenza in-
fection in neonates, we adoptively transferred adult CD8 T cells
into neonatal mice before infection with influenza. Our data dem-
onstrate that the insufficient production of IFN- by neonatal
CD8 T cell may be responsible for the long-term pulmonary in-
flammation and lung injury in influenza-infected neonatal mice.
Materials and Methods
Mice
BALB/c mice were purchased as breeders from Harlan Sprague Dawley.
IFN- knockout mice (C.129S7(B6)-Ifngtm1Ts/J) were purchased from The
Jackson Laboratory. Mice were maintained under specific pathogen-free
conditions within the vivarium at Louisiana State University Health Sci-
ences Center (New Orleans, LA). Sentinel mice within each colony were
monitored and were negative for specific known mouse pathogens. Breed-
ers were time-mated and 7-day-old pups (neonates) were used for exper-
iments. All animal protocols were prepared in accordance with the Guide
for the Care and Use of Laboratory Animals (22) and approved by the
Institutional Animal Care and Use Committee at Louisiana State Univer-
sity Health Sciences Center.
Viral infection and viral titer determination
Human influenza A/PR/8/34 (H1N1) was purchased as a sucrose gradient-
purified virus from Advanced Biotechnologies. The virus preparation was
determined to be free of bacteria, yeast, and fungi. Viral titer was measured
in whole lung homogenates at different time points (Fig. 1) using the
TCID50 method of Spearman and Kärber (23, 24). Mardin-Darby canine
kidney cells were seeded on a 96-well plate and then inoculated with a
series of 10-fold dilutions of lung homogenates. Cells were then incubated
at 37°C and 5% CO2 for 4 days; wells showing cytopathic effects were
counted and TCID50 were calculated.
Experimental design
Seven-day-old pups were infected intranasally with 10 TCID50/g body
weight of influenza (FLU) in 10 l of Dulbecco’s PBS or sham infected
with 10 l Dulbecco’s PBS (SHAM). Mouse pups were then allowed to
mature and various assays were performed at the indicated time points as
outlined in Fig. 1A. For adoptive transfer studies, CD8 T cells from naive
wild-type adults (FLU/CD8A), wild-type neonates (FLU/CD8N), or IFN-
knockout mice (FLU/CD8AKO) were administered i.p. to 6-day-old pups;
at 7 days of age, these pups were then infected with influenza (Fig. 1B).
Four groups of mice were included as controls: vehicle-treated pups
(SHAM), influenza-infected pups (FLU), vehicle-treated adult mice
(ASHAM), and influenza-infected adult mice (AFLU). A range of assays
were performed at indicated time points as shown in Fig. 1B.
Pulmonary function test
Pulmonary function, specifically the respiratory mechanics, were measured
using an invasive method as previously described (20). Briefly, anesthe-
tized mice were intubated and mechanically ventilated by a computer con-
trolled piston ventilator (flexiVent, Scireq). Mice were then challenged by
FIGURE 1. Outline for the experimental study protocol. A, Seven-day-old mouse pups were infected intranasally with 10 TCID50 H1N1/g whole body
weight (FLU), while a control group of mice was mock-infected with vehicle (SHAM). BALF was isolated at 0.2, 2, 4, 10, and 109 dpi. Lungs were isolated
for viral titer assays at 2, 5, and 10 dpi; for histopathology at 10 and 109 dpi; and for evaluation of T cell subpopulations (T pop) at 7 dpi. Pulmonary
function (PFT) was tested at 109 dpi. B, For the adoptive transfer study, 6-day-old pups were administered CD8 T cells purified from the spleens of naive
neonatal (7 days old, CD8N), adult (4 wk old, CD8A), or adult IFN--deficient (4 wk old, CD8AKO) mice. Pups were infected with influenza (FLU) at
7 days of age and allowed to mature until 37 days of age (30 dpi). Four control groups were included: neonatal or adult noninfected mice (SHAM and
ASHAM, respectively) and neonatal or adult influenza-infected (FLU and AFLU, respectively). Viral titers were measured at 4 and 30 dpi. Pulmonary
function test, BALF cellularity, and lung histopathology were measured at 30 dpi.
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an aerosolized bronchoconstrictor methacholine (Sigma-Aldrich) at in-
creasing doses (methacholine (MeCh): 0, 25, and 50 mg/ml). At each dose,
lung resistance and compliance were calculated using the single compart-
ment model.
Lung histopathology
At different time points, lungs were perfused, inflated by gentle infusion of
HistoChoice tissue fixative (Amresco) to tidal volume (6 ml/kg), and iso-
lated (Fig. 1). The fixed lungs were then dehydrated, embedded in paraffin,
and sectioned at 4 m. Each lung section was stained with either H&E or
periodic acid-Schiff (PAS). Specific histopathological diagnoses were per-
formed by unbiased pathologists (D.T. and D.S.).
Initial observations of the influenza-infected lungs suggested emphyse-
matous-type lesions. Morphometric analyses of the lung sections were used
to quantify these changes in lung architecture, including airspace enlarge-
ment (i.e., mean linear intercept, or Lm) and destruction of the alveolar
walls (i.e., destructive index, or DI). Lm was quantified using the National
Institutes of Health Image program (http://rsb.info.nih.gov/nih-image). The
number of alveolar wall intersections was counted on 12 nonoverlapping
lung fields and was expressed as micrometers using a protocol adapted
from Thurlbeck (25). To measure DI, a grid with 42 equidistant points (100
m between each point) was placed at the center of and superimposed on
the lung field. Structures lying under these points were classified as normal
(N) or destroyed (D) alveolar and/or duct spaces. Points falling over other
structures, such as duct walls, alveolar walls, and such were excluded from
the calculations. The DI was calculated from the formula: DI  D/(D 
N)  100 (26).
Bronchoalveolar lavage fluid (BALF) cellularity and cytokine
measurement
BALF was isolated in 1 ml of PBS containing 2% heat-inactivated FBS at
the indicated time points (Fig. 1). The cells were then centrifuged onto
slides and stained using a Hema-3 staining kit (Fisher Scientific). Two
unbiased readers counted a total of 300 cells per slide and recorded the
differential cell counts based on the morphology and staining of the cells.
Cytokine levels were measured from 50 l of cell-free BALF using a
high-throughput multiplex cytokine assay system (x-Plex Mouse Assay;
Bio-Rad) according to the manufacturer’s instructions. Each sample was
analyzed in triplicate on the Bio-Plex 200 system (Bio-Rad). A broad sen-
sitivity range of standards ranging from 1.21 to 37,312 pg/ml (depending
on the analyte) was used to quantitate a dynamic range of cytokine con-
centrations. The concentrations of analytes in these assays were quantified
using a standard curve, and a five-parameter logistic regression was per-
formed to derive an equation that was then used to predict the concentra-
tion of the unknown samples. The following cytokines were assayed: IL-2,
IL-4, IL-5, IL-6, IL-12p40, IL12p70, IL-13, IL-17, IFN-, and TNF-. The
data presented herein excluded any number below the range of sensitivity
for the particular analyte.
Assessment of pulmonary T cell populations
A single-cell suspension of lung cells was prepared using a standardized
protocol (27). Briefly, lungs were perfused, excised, cut into small pieces,
and incubated at 37°C for 1 h in RPMI 1640 media supplemented by 2%
heat-inactivated FBS, 1 mg/ml collagenase I (Invitrogen), and 150 g/ml
DNase I (Sigma-Aldrich). After incubation, single cells were obtained by
mashing the lung pieces through a 40-m cell strainer (BD Biosciences).
RBC were lysed using 1 RBC lysis buffer (eBioscience), and the remain-
ing cells were stimulated for 5 h with 5 ng/ml PMA and 500 ng/ml iono-
mycin (Sigma-Aldrich) in the presence of a protein transport inhibitor (1
l/L  106 cells; GolgiPlug, BD Biosciences). After stimulation, cells
were harvested, fixed, permeabilized (fixation and permeabilization buffer;
eBioscience), and stained with the following Abs purchased from
eBioscience: Pacific Blue-CD3 (17A2), PerCP-CD4 (RM4-5), Alexa Fluor
488-CD8a (53-6.7), PE-IFN- (XMG1.2) and PE-Cy7-IL-4 (11B11). Cell
surface staining (i.e., CD3, CD4, and CD8) was performed before fixation/
permabilization. To evaluate influenza-specific CD8 T cell response, lung
cells were stained with allophycocyanin-labeled H-2Kd tetramer com-
plexed with the immunodominant epitope TYQQRTRALV (H-2Kd/
TYQQRTRALV, Immunomics) from influenza A nucleoprotein without
PMA/ionomycin stimulation. Cell staining was determined with an LSRII
(BD Biosciences) flow cytometer after gating on the lymphocyte popula-
tion as determined by forward and side scatter properties. Flow data were
analyzed and plotted using FlowJo software (version 7.2.2 for Windows,
Tree Star).
Adoptive transfer of CD8 T cells
The protocol is modified from the method developed by Wells et al. (28).
In brief, single-cell suspensions were prepared from the spleens of young
adult (4 wk of age), adult IFN- knockout mice (4 wk old), or neonatal
(7-day-old) mice using a standardized protocol as above. CD8 T cells
were then isolated using a negative selection strategy according to the
manufacturer’s directions (mouse CD8 T cell enrichment kit, StemCell
Technologies). Neonatal, adult, or IFN- knockout adult CD8 T cells
(4  106 in 25 l of PBS) were then injected i.p. into 6-day-old pups
(CD8N, CD8A, CD8AKO, respectively).
Statistical analysis
All data were plotted as means  SEM and analyzed using GraphPad
Prism software (version 5.0.0). Two-way ANOVA and Bonferroni post-
tests were used to test for differences between the groups for the pulmonary
function, BALF cellularity, cytokine assays, and T cell populations. Stu-
dent’s t test was used to analyze the differences in lung histopathology
parameters (Lm and DI). Differences were considered statistically signifi-
cant if p  0.05.
Results
Neonatal influenza infection resulted in acute pulmonary
inflammation
BALB/c pups were infected at 7 days of age with 10 TCID50 of
influenza A virus/g body weight (FLU); controls received ster-
ile Dulbecco’s PBS (SHAM). Mice infected with this sublethal
dose (90% survival) of influenza developed mild-to-moderate
illness, which was characterized by ruffled fur and significant
reductions in weight gain compared with SHAM. By 18 days
postinfection (dpi), mice infected with influenza weighed 12%
less than SHAM animals ( p  0.05). Infectious influenza virus
was detected in whole lung homogenates in neonatal mice as
early as 2 dpi (104.49  0.03 TCID50/g lung tissue) and peaked at
5 dpi (106.93  0.25 TCID50/g lung tissue). No infectious viruses
were detected in neonatal or adult mice after 7 dpi.
To measure pulmonary inflammation, BALF cellularity, BALF
cytokine levels, and lung histopathology were monitored through-
out the course of the infection (Figs. 2 and 3). All results from
SHAM mice at different time points (5 h, 1, 2, 4, and 10 days
postinfection) were similar and showed no difference (data not
shown), and therefore only data from 10 dpi were presented as a
representative. Mice infected with influenza recruited significantly
more inflammatory cells to the lung as observed in both the lung
and the BALF. Monocytes/alveolar macrophages (AMs) were
shown to be recruited to the bronchoalveolar space as early as 5 h
postinfection (hpi, Fig. 2A), and significantly more cells compared
with SHAM were observed at 4 and 10 dpi with the peak at 10 dpi
(44.09  6.83 vs 13.19  1.92  104). Neutrophils in the BALF
showed the same trend. They peaked at 2 dpi (3.20  1.11 vs
0.12  0.02  104) and remained elevated at 10 dpi compared
with the SHAM group (2.58  0.75 vs 0.08  0.03  104). A
significant increase in lymphocytes was observed at 10 dpi (8.47 
3.79 vs 0.01  0.01  104). Total BALF cell numbers were 5-fold
higher in the FLU group compared with the SHAM group at 10 dpi
(61.30  10.70 vs 13.30  1.92  104, p  0.05).
Cytokines in the BALF peaked at various times during the in-
fection (Fig. 2B). Although a total of 10 cytokines (IL-2, IL-4,
IL-5, IL-6, IL-12p40, IL-12p70, IL-13, IL-17, IFN-, and TNF-)
were measured, only six (IL-5, IL-6, IL-12p40, IL-13, IFN-, and
TNF-) were detectable at the time points tested. Of those cyto-
kines detected (with the exception of IFN-), all were elevated at
5 hpi. TNF- was one of the earliest cytokines detected and was
present in the highest concentration at 5 hpi (72.0  2.55 pg/ml).
It remained significantly elevated at 2 dpi (65.0  28.3 pg/ml) and
was undetectable by 10 dpi. IL-12p40 gradually increased from 5
hpi to 10 dpi, where it became significantly elevated over SHAM
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(61.4  7.51 pg/ml). IFN- was only detectable at 2 (20.1  10.9
pg/ml) and 4 dpi (21.5  0.00 pg/ml). The other three cytokines
(IL-5, IL-6, and IL-13) were detected at all time points but were
not significantly different than in SHAM-treated mice.
Histopathologic examination of lungs from neonatally infected
mice revealed marked pulmonary inflammation that was observed
in the perivascular, peribronchial, and alveolar spaces of the lung
at 10 dpi (Fig. 3A, right panel). The inflammatory infiltrates con-
sisted of lymphocytes and occasional plasma cells. Additionally,
extensive mucus production was observed in the goblet cells of the
infected lungs, along with proliferation of peribronchial glands
within the hilum (Fig. 3B, right panel). Diffuse emphysematous
changes with a slight thickening of the alveolar walls and vascular
congestion were also observed. In contrast, SHAM lungs showed
normal thickening of the alveolar wall with no inflammation (Fig.
3A, left panel) and no mucus staining (Fig. 3B, left panel).
Neonatal influenza infection led to long-term pulmonary
dysfunction and injury
To investigate the long-term effects of neonatal influenza infection,
a group of 7-day-old pups were infected with the virus and allowed
to mature to 116 days of age (109 dpi, Fig. 1A). As with the acute
studies, BALF cellularity, BALF cytokine levels, and lung histo-
pathology were recorded at 109 dpi.
Significantly more total cells were present in the BALF of pre-
viously infected mice compared with SHAM animals at 109 dpi
(6.05  1.89 vs 2.59  0.70  105, p  0.05). As shown in Fig.
4, there were significantly more monocytes/AMs (51.02  8.79 
104) present in the BALF of infected animals compared with
SHAM mice (25.08  5.17  104). Neutrophils (14.42  6.47 
104) and lymphocytes (6.20  3.24  104) were higher than in
SHAM mice (1.08  0.53 and 0.25  0.07  104, respectively),
although not significantly different ( p  0.074). Eosinophils were
not observed in the BALF of either FLU or SHAM mice. None of
the cytokines assayed in the BALF at 109 dpi was significantly
different than that of controls (data not shown).
The persistent change in BALF cellularity at 109 dpi suggested
that there might also be unresolved pulmonary inflammation in the
lungs of the adult mice initially infected with influenza as neo-
nates. Indeed, lung histopathologic examination (Fig. 5A, right
panel) confirmed mild-to-moderate peribronchial chronic inflam-
mation consisting mostly of lymphocytes. Furthermore, moderate
mucus production was still present in the goblet cells of infected
lungs (Fig. 5B, right panel). Diffuse emphysematous changes with
focal areas of minimal thickening within the alveolar walls were
also observed in the infected lungs. Emphysematous lesions were
FIGURE 2. BALF cellularity and cytokine levels in neonatal mice after
infection. A, BALF was isolated and the cellularity determined at 5 hpi and
at 2, 4, and 10 dpi. Absolute cell numbers were plotted vs time postinfec-
tion (n  4–5/group). Mac indicates macrophages; Neu, neutrophils; Lym,
lymphocytes; Eos, eosinophils. B, Cytokine levels in the BALF supernatant
were determined for the following cytokines: IL-2, IL-4, IL-5, IL-6, IL-
12p40, IL-12p70, IL-13, IL-17, IFN-, and TNF-. Only detected cyto-
kines are displayed on the graph (n  3–5/group). Data are expressed as
means  SEM: , p  0.05; , p  0.01; and , p  0.001 compared
with SHAM.
FIGURE 3. Lung histopathology following neonatal influenza infec-
tion. Lungs were isolated, fixed, and stained with H&E and PAS at 10 dpi.
A, H&E staining showed marked inflammation in the perivascular, peri-
bronchial, and alveolar spaces of the infected lung (right panel). Diffuse
emphysematous changes were also observed in the infected lungs along
with slight thickening of the alveolar walls. SHAM mice showed no in-
flammation or emphysematous changes (left panel). Scale bar  100 m.
B, PAS staining demonstrated widespread mucus production and prolifer-
ation of peribronchial glands within the hilum in the influenza-infected
mice (right panel). SHAM mice showed no mucus staining. Scale bar  50
m. Each image is representative of four different animals.
FIGURE 4. BALF cellularity in adult mice infected with influenza as
neonates. BALF was isolated at 109 dpi and leukocyte populations were
determined. Data are expressed as means  SEM (n  4–5/group): , p 
0.05. Mac indicates macrophages; Neu, neutrophils; Lym, lymphocytes;
Eos, eosinophils.
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quantified by evaluating both the airspace enlargement in terms of
Lm and the destruction of the alveolar walls by measurement of DI.
Influenza-infected lungs exhibited a marked increase of alveolar
enlargement (Lm of 79.0  2.89 m) compared with SHAM
(60.0  5.15 m) and a significant increase in destroyed alveolar
walls (DI of 57.1  2.91 m) vs SHAM (14.5  0.58 m).
The change in lung structure associated with the persistence of
inflammatory cells in the lung and the BALF suggested alterations
in pulmonary function. To determine whether neonatal infection
with influenza produced long-term effects on lung function, lung
mechanics were measured in mechanically ventilated animals at
109 dpi. Mice infected with influenza as neonates had significantly
impaired lung function compared with SHAM as evidenced by
increased airway hyperreactivity with decreased dynamic com-
pliance in response to MeCh (Fig. 6). Baseline resistance was
similar in these two groups at this time point (0.49  0.03 vs
0.47  0.08 cm H2O  s/ml). Although there was no significant
shift to the left in the MeCh dose-response curve, influenza
infection increased pulmonary resistance in response to MeCh
(4.12  0.93 vs 1.25  0.21 cm H2O  s/ml, Fig. 6A) and, there-
fore, airway hyperreactivity.
Reduced IFN- T cells are observed in the neonate in
response to influenza infection
To dissect the possible mechanism(s) responsible for the observed
long-term pulmonary dysfunction, pulmonary T cell responses
were measured using intracellular cytokine staining in influenza
infected neonates (FLU) and adults (AFLU; 4 wk old) at 7 dpi
(Fig. 7A). Approximately 2-fold more CD8 T cells (9.7  1.1 vs
5.2  1.3  105) and slightly more CD4 T cells (1.67  0.18 vs
1.41  0.48  106) were present in the adult lungs compared with
the neonatal lungs (Fig. 7, A and B, left panel). Additionally, ne-
onates infected with influenza appeared to mount a weak IFN-
response to the virus compared with that of adults (Fig. 7, A and B,
middle panel). Adult mice infected with influenza (AFLU) were
able to recruit almost 6-fold more CD8IFN- T cells (12.3 
1.92 vs 2.76  1.92% of CD8 T cells) and 2-fold more
CD4IFN- T cells (4.04  0.67 vs 1.92  0.34% of CD4 T
cells) to the lung as compared with the neonates. CD4IFN- T
cells in neonates were statistically different from SHAM levels
(0.61  0.07% of CD4 T cells). No difference was observed in
the number of CD4IL-4 T cells recruited to the lungs of mice
infected with influenza as neonates or adults (data not shown). To
examine the specificity of the CD8 T cells recruited to the lung,
we stained lung lymphocytes with H-2Kd tetramers containing the
immunodominant epitope from the influenza nucleoprotein (Fig.
7B, right panel). Influenza infection of adult mice resulted in the
recruitment of about 2-fold more CD8 T cells that bound the
influenza tetramer compared with infection of neonatal mice
(2.29  0.16% vs 1.24  0.04%).
Reversal of long-term pulmonary dysfunction after adoptive
transfer of adult CD8 T cells but not neonatal CD8 T cells
To determine whether the persistent pulmonary inflammation, al-
tered lung structure, and long-term lung dysfunction were due to
the functional immaturity of host lymphocytes or other factors
(e.g., IFN-), CD8 T cells were purified from the spleen of naive
neonatal, adult, or adult IFN--deficient mice and adoptively trans-
ferred to 6-day-old pups (Fig. 1B). One day later, these mice were
then infected with 10 TCID50/g body weight of influenza (FLU/
CD8N, FLU/CD8A, or FLU/CD8AKO, respectively). In addition,
neonatal and adult mice were simply infected with influenza (FLU
and AFLU, respectively). Pulmonary function testing, BALF cel-
lularity, and lung histopathology were performed at 30 dpi.
Both FLU/CD8N and FLU/CD8A groups showed an improve-
ment in pulmonary function, as evidenced by lower airway hyper-
reactivity compared with control FLU mice (2.89  0.94 and
1.45  0.46 vs 5.17  1.35 H2O  s/ml at 50 mg/ml MeCh, Fig.
8A). Since noninfected control mice, either adults or neonates at
time of sham infection, exhibited almost identical responses (data
FIGURE 5. Adult lung histopathology of mice infected with influenza
as neonates. Lungs were isolated, fixed, and stained by H&E and PAS at
109 dpi. A, Mild-to-moderate peribronchial chronic inflammation consist-
ing mostly of lymphocytes and diffuse emphysematous changes were ob-
served in the lungs of mice infected with influenza as neonates (right
panel). No inflammation or emphysematous changes were observed in
SHAM mice (left panel). Scale bar  100 m. B, Moderate mucus pro-
duction persisted in airway epithelial cells of influenza-infected mice (right
panel), while no mucus staining was observed in the lungs of SHAM-
infected mice. Scale bar  50 m. Each image is a representative of three
animals.
FIGURE 6. Persistent airway dysfunction in adult mice infected with
influenza as neonates. Pulmonary function was assayed at 109 dpi. A, In-
fluenza-infected mice showed a significant increase in lung resistance com-
pared with sham-inoculated mice when challenged by 50 mg/ml MeCh.
There was no difference in baseline resistance between the FLU and
SHAM groups. Data were normalized to baseline (0 mg/ml MeCh) and are
expressed as means  SEM (n  5/group). , p  0.001. B, These same
mice exhibited a marked decrease in lung compliance if they were infected.
For simplicity in interpretation, data are presented as normalized to base-
line (0 mg/ml MeCh) and expressed as means  SEM (n  5/group).
, p  0.01.
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not shown), only the noninfected control mice that were sham
infected as neonates (SHAM) are presented. Compared with the
FLU/CD8N group, the FLU/CD8A group showed significantly
lower pulmonary resistance at 50 mg/ml MeCh (1.00  0.17 cm
H2O  s/ml). Moreover, the resistance of FLU/CD8A mice was
comparable to that of SHAM mice (1.25  0.21 cm H2O  s/ml).
In contrast, FLU/CD8N mice had higher resistance compared with
SHAM mice, although pulmonary resistance was lower than that
of the FLU mice (2.05  0.39 vs 4.12  0.93 cm H2O  s/ml).
Interestingly, AFLU mice showed medium airway hyperreactivity:
lower than mice infected as neonates (FLU) and higher than FLU/
CD8A mice. Finally, adoptive transfer of adult CD8 T cells de-
ficient in IFN- prior to infection (FLU/CD8AKO) was unable to
reverse the effects on pulmonary dysfunction observed in mice
infected with influenza as neonates (resistance at 50 mg/ml MeCh
of 5.80  1.83 vs 5.17  1.35 H2O  s/ml).
Lung histopathology was also greatly improved in the FLU/
CD8A mice as compared with FLU, FLU/CD8N, and FLU/
FIGURE 7. Lymphocyte populations in the lungs of mice infected with
influenza as neonates and adults. T cell subpopulations were analyzed in
lung homogenates at 7 dpi in mice infected at either 7 days (FLU) or 4 wk
(AFLU) of age using intracellular cytokine staining and flow cytometry. A,
Representative flow cytometry dot plot of IFN- CD4 and CD8 T cells
in infected adult or neonatal mice. B, Both CD4 and CD8 T cells ap-
peared to be elevated in influenza-infected adults (AFLU) compared with
mice infected as neonates (FLU, left panel). IFN- CD4 and CD8 T
cells were significantly greater in influenza-infected adults as compared
with infected neonates (middle panel). Finally, CD8 T cells specific for an
immunodominant epitope of influenza in AFLU mice were also signifi-
cantly greater than in FLU mice (right panel).
FIGURE 8. Pulmonary function, BALF cellularity, and lung histopa-
thology following adoptive transfer of CD8 T cells. Neonatal (FLU/
CD8N), adult (FLU/CD8A), or adult IFN--deficient CD8 T cells (FLU/
CD8AKO) were administered 1 day before influenza infection of neonatal
mice. A, Pulmonary function was assayed at 30 dpi. Mice receiving either
adult or neonatal CD8 T cells exhibited improved pulmonary function as
demonstrated by a reduction in airway hyperreactivity compared with
control mice infected with influenza (FLU), while mice receiving adult
IFN--deficient CD8 T cells showed no improvement in lung function.
Adoptive transfer of adult CD8 T cells completely reversed airway
hyperreactivity to SHAM levels, while FLU/CD8N mice still showed
increased airway hyperreactivity compared with SHAM. Data were nor-
malized to baseline (0 mg/ml MeCh) and are expressed as means 
SEM (n  4 –7/group): , p  0.001 compared with SHAM; #, p 
0.05; ##, p  0.01; and ###, p  0.001 compared with FLU. B, BALF
cellularity. There were less monocytes/AMs and lymphocytes in FLU/
CD8A mice compared with FLU mice. BALF cellularity for FLU/
CD8N and FLU/CD8AKO mice was similar to FLU mice. Data were
expressed as mean  SEM (n  4 –7/group): , p  0.05; , p  0.01;
and , p  0.001 compared with SHAM; #, p  0.05 compared with
FLU mice. Mac indicates macrophages; Neu, neutrophils; Lym, lym-
phocytes; Eos, eosinophils. C, Lung pathology was assessed at 30 dpi.
Substantial reductions in pulmonary infiltrates are observable in the
lungs of mice receiving adult CD8 T cells (FLU/CD8A) before infec-
tion as compared with all other groups. Other groups included: mice
infected as neonates (FLU); mice receiving CD8 T cells from naive
wild-type adults (FLU/CD8A), wild-type neonates (FLU/CD8N), or
IFN- knockout mice (FLU/CD8AKO) before infection; and adult in-
fected mice (AFLU). Scale bar  100 m.
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CD8AKO mice. These improvements included reduced pulmonary
inflammation (Fig. 8C) and mucus production (data not shown) in
the infected lungs at 30 dpi. Adoptive transfer of adult CD8 T
cells was not able to completely reverse pulmonary inflammation
at 30 dpi, since small foci of inflammatory cells were still observed
in the peribronchial and perivascular areas of the lung (Fig. 8C).
Although the lungs from AFLU mice exhibited similar levels of
inflammation as observed in the FLU, FLU/CD8N, and FLU/
CD8AKO mice (Fig. 8C), there were no emphysematous-type le-
sions and little to no mucus (data not shown).
BALF cellularity showed the same trend (Fig. 8B). FLU/CD8A
had fewer monocytes/AMs (18.07  1.32 vs 39.24  9.35  104)
and lymphocytes (0.37  0.24 vs 2.82  1.41) in BALF compared
with FLU controls, although a significant amount of neutrophils
were still present (10.54  3.23 vs 12.40  3.61  104). Con-
versely, transfer of neonatal CD8 T cells (FLU/CD8N) or adult
IFN--deficient CD8 T cells (FLU/CD8AKO) prior to infection
did not reduce cellular infiltrates in BALF, as there were no dif-
ferences observed between these two groups and FLU controls.
Interestingly, adult mice infected with influenza (AFLU) had sig-
nificant elevated numbers of neutrophils and lymphocytes, but not
monocytes/AMs, in their BALF compared with SHAM mice.
The ability of neonatal mice to resolve infection following adop-
tive transfer of the adult or neonatal CD8 T cells was then ana-
lyzed. Viral titers were determined at 4 and 30 dpi from lung
homogenates. The FLU/CD8A group showed a significantly lower
viral load compared with FLU mice (102.80  0.040 vs 106.42  0.53
TCID50/g lung tissue). AFLU mice also had lower viral titers than
FLU mice (103.57  0.18 vs 106.42  0.53 TCID50/g lung tissue).
Additionally, FLU/CD8A mice had a significantly lower viral load
than did AFLU mice at 4 dpi (102.80  0.040 vs 103.57  0.18
TCID50/g lung tissue). No significant differences were observed
between FLU/CD8N and FLU or FLU/CD8AKO and FLU mice,
although titers in both groups were slightly lower than in the FLU
group (data not shown). At 30 dpi, virus was no longer detectable
in any group.
Discussion
In the present study, we described a neonatal mouse model of
influenza A infection. In this model, BALB/c mice were infected
with influenza virus at 7 days of age and allowed to mature. The
mice developed acute, severe pulmonary inflammation, which re-
mained unresolved 4 mo later and long after influenza virus was no
longer detectable. This correlated with significant increases in pul-
monary resistance in response to increasing doses of methacholine
(i.e., airway hyperreactivity) and decreases in compliance at 4 mo.
Histopathologic analysis of the lungs from adult mice infected as
neonates revealed emphysematous-type lesions characterized by
airspace enlargement and destruction of alveolar walls. Adoptive
transfer of adult CD8 T cell into the pups before infection with
influenza reversed the effects of neonatal influenza infection as
evidenced by enhanced pulmonary function (returning airway re-
sistance to SHAM levels) and reduced pulmonary inflammation
and reduced viral load compared with pups receiving neonatal
CD8 T cells. Adoptive transfer of adult CD8 T cells deficient in
IFN- indicated that IFN- was critical in determining disease
outcome.
The inflammatory cells in the BALF during the acute phase (5
hpi to 10 dpi) and chronic phase (109 dpi) included monocytes/
AMs, lymphocytes, and neutrophils. Interestingly, although there
were more cells in the BALF at 10 dpi than at 109 dpi (50%
more), the composition of the BALF was not significantly altered
(i.e., both were comprised of 80% of monocytes/AMs and 20%
of lymphocytes and neutrophils), suggesting the continued pres-
ence or secretion of chemokines responsible for neutrophil and
lymphocyte recruitment even in the absence of detectable infec-
tious virus or viral Ag. At 109 dpi, we were unable to detect dif-
ferences in cytokines between mice infected as neonates and
SHAM controls; however, the role of other cytokines or inflam-
matory mediators (e.g., leukotrienes) cannot be excluded.
In addition to the chronic inflammation and airway hyperreac-
tivity to MeCh, histopathologic analysis of the lungs from adult
mice originally infected as neonates revealed emphysematous-type
lesions within the lung architecture. Intriguingly, there were no
differences in baseline resistance between this group and SHAM
controls at 109 dpi despite significant differences in lung architec-
ture and inflammatory state. The reason(s) for this are unclear, but
may represent masking due to the persistent inflammation or a
limitation of the model chosen (i.e., single compartment) to mea-
sure respiratory mechanics.
In general, the immune system of a neonate is quite different
from that of an adult, in that the innate and adaptive immune re-
sponses are immature (29, 30). Naive, neonatal T cells are also
functionally distinct from adult T cells (31), and effector, neonatal
T cells are less able to lyse Ag-bearing cells or produce cytokines
(32). Although neonatal T cells are able to mount comparable pro-
liferative responses to mitogens (33), they have intrinsically lower
levels of CD3/TCR, adhesion molecules, and costimulatory mol-
ecules (34). Data from our studies indicate that recruitment of T
cells is different in the infected neonates vs the adult, and although
both T cell populations are induced in the neonate, CD8 T cell
numbers are doubled in the adults. This suggested that cell number
alone may have been responsible for the pathophysiological im-
pact of neonatal influenza infection. Although adoptive transfer of
neonatal CD8 T cells before infection did help to control the
infection (i.e., reduced viral load and improved pulmonary func-
tion compared with neonates infected with influenza), it was not as
effective as adoptive transfer of adult CD8 T cells (i.e., further
reduction in viral load and pulmonary function equivalent to that
of SHAM). These data suggest that neonatal CD8 T cells are
functionally impaired compared with adult CD8 T cells.
In addition to the lower magnitude of the T cell response in the
neonates, the numbers of IFN-CD8 T cells was significantly
lower than those of their adult counterparts after influenza infec-
tion. Previous studies have showed that IFN- plays an important
role in recovery from influenza infection by helping to clear the
virus (35, 36) and that adoptive transfer of Tc1 cells (IFN-high
CTLs) promotes clearance of the influenza virus, while transfer of
Tc2 cells (IFN-low CTLs) does not affect viral clearance (37). Our
data confirmed that IFN- produced by CD8 T cells was impor-
tant to effectively clear influenza from the neonatal lung, since
mice receiving IFN--deficient adult CD8 T cells showed higher
viral loads than mice receiving wild-type adult CD8 T cells.
Moreover, adoptive transfer of IFN--deficient CD8 T cells to-
tally abolished the benefits observed upon administration of adult
CD8 T cells, as demonstrated by increased airway hyperreactiv-
ity, BALF cellularity, and lung histopathology (similar to neonatal
infection controls). Collectively, our data further demonstrate the
importance of IFN- in the resolution of infection and inflamma-
tion initiated upon infection of neonatal mice.
Viral load and immune function are inescapably linked. Also, it
is readily apparent that CD8 T cells do not directly affect disease
outcome and that they alter the course of pathogenesis by acting
against virus-infected cells (i.e., decreasing viral load) through
production of IFN-. This contention is strengthened by our ob-
servation that introduction of poorly functional neonatal CD8 T
cells does not ameliorate disease or act against virus-infected cells,
thereby permitting a higher viral load in the host. Mice receiving
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wild-type adult CD8 T cells exhibited lower viral loads, im-
proved pulmonary function, a reduction in total BALF cellularity,
and a reduction in pulmonary inflammation compared with mice
infected as adults.
Influenza and another common respiratory virus, RSV, infect
the same human population (infants) but elicit different pulmonary
diseases. It has been reported that Th2 (IL-4 Th cells) responses
dominate in neonatal immunity, while Th1 (IFN- Th cells) re-
sponses dominate in adults (38–42). However, studies from our
laboratory and those of other groups clearly demonstrate that the
immune response initiated by neonates is more complex (20). A
previous study showed that RSV-infected neonatal mice mount a
Th2-biased response when rechallenged as adults with RSV (18).
Although a mixture of Th1 and Th2 cells is elicited in lungs during
reinfection, there were significantly more (4-fold) Th2 cells in
lungs compared with mice primarily infected as adults (18). Data
from our laboratory showed that even at primary infection, neo-
natal RSV infection mounts a Th2-skewed response (20) compared
with influenza infection (data presented herein). In fact, both in-
fections mount a mixed Th1/Th2 response. Following influenza
infection, 5-fold more Th1 cells than Th2 cells were recruited to
the lungs, while RSV infection recruited similar numbers of Th1
and Th2 cells. These data suggest that the immune response ini-
tiated in neonates is not predestined toward a Th2 response, as
previously implied, and appears to depend on the Ag encountered.
Besides the differences in responses of helper T cells to RSV and
influenza, both viruses induce a weak CD8 T cell response sim-
ilar in magnitude and function. Finally, during neonatal RSV in-
fections, although airway remodeling is present (i.e., increased
basement membrane thickness, smooth muscle hypertrophy, sub-
epithelial fibrosis), there is relatively no tissue destruction (20). In
contrast, neonates infected with influenza exhibited a tremendous
amount of tissue destruction, which may be the principal determi-
nant of the severity of airway symptoms. Taken together, there is
similarity and disparity in the immune responses induced by RSV
and influenza, and the immune and cytopathic differences may
explain the specific pulmonary diseases elicited by these two
viruses.
In summary, our data demonstrate that infection of newborn
mice with influenza has long-term consequences for the host, in-
ducing diffuse emphysematous changes in the lung and marked
pulmonary inflammation. These alterations were persistent and as-
sociated with increased airway resistance and reduced compliance.
The adaptive T cell response was markedly reduced in the neo-
nates, with the most striking difference being observed among the
CD8 T cell population. Our adoptive transfer data suggest that
the immaturity of this cell population is an important factor in
determining disease outcome in the context of the pulmonary mi-
croenvironment. These data, along with recent data suggesting that
one lung infection has the potential to modify immunity for ex-
tended periods of time (43), emphasize the importance of delaying
the time of initial influenza infection, and therefore the importance
of vaccination in infants and young children. Future studies to
elucidate the molecular mechanisms responsible for the persistent
inflammation and structural alterations observed with neonatal in-
fluenza infection should identify important therapeutic targets ca-
pable of controlling long-term complications due to viral bronchi-
olitis in infancy. Our observations (i.e., that CD8 T cell responses
in neonates are functionally different from those of adults) have
significant implications for human infants beyond just influenza
infection, including infant responses to nosocomial infections and
even responses to vaccination.
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